ACT government considers Mind Medicine Australia reform to allow psychedelics
Canberra Times, May 29, 2022
The ACT government is considering legislation changes to allow MDMA-assisted therapy to treat post-traumatic stress disorder and psilocybin to treat depression.
Michael finds a way to see ‘beautiful things’ again
CBR Business News, May 24, 2022
Royal Australian Air Force officer of 16 years, Michael Raymond, speaks about psychedelic-assisted therapies.
Insight Ep 13: Illicit Medicine
SBS, May 9, 2022
Is the war on drugs holding us back from developing new therapies, and denying people viable treatments?
Biotechs want to unlock the psychedelics market, but it isn’t simple
The Sydney Morning Herald, May 8, 2022
Australian biotechs are high on optimism about the multi-billion dollar potential of psychedelic treatments for mental health, but regulators still have question marks.
The Year that Made Me: Tania De Jong, 2017
ABC Sunday Exgra, April 24, 2022
MMA’s Executive Director, Tania de Jong AM, talks about undergoing psychedelic therapy and the focus it gave her. She is currently in rehearsal for the premiere season of the musical, Driftwood, which is based on the memoir of her mother, Eva, and the story of her grandparents, who escaped the Holocaust.
Could psychedelic mushrooms be the answer to treating depression?
6PR Mornings with Liam Bartlett, April 13, 2022
Listen to our Executive Director, Tania de Jong AM, discuss the potential in psychedelic medicines on 6PR Mornings with Liam Bartlett.
PharmAla Biotech to supply Mind Medicine Australia with GMP MDMA for Clinical Trial
News Wire, April 8, 2022
PharmAla’s GMP MDMA will accelerate trial work funded by Australia’s premier Psychedelics charity.
Professor David Nutt (UK) Interview on FM104
FM104, April 5, 2022
Mind Medicine Australia Ambassador Professor David Nutt (UK) discusses the current state of psychedelics including the progress with Mind Medicine Australia.
State roadblocks TGA approval of psychedelic-assisted therapies
6PR Mornings, February 10, 2022
Former Chief of Australia’s Defence Force and Mind Medicine Australia board director Professor Admiral (Ret) Chris Barrie AC said Australia’s TGA has given 40 approvals to doctors to provide certain treatments to patients suffering from treatment-resistant PTSD on a case by case basis.
But these approvals are being blocked at the state level.
In Canada, which has a similar health system to Australia, doctors require just one simple approval, which makes access easier.
Mr Barrie says Australia needs to follow suit, with these treatments the only hope for many Veterans suffering PTSD.
‘This is not palliative care; this is curative’: How MDMA could be used to treat depression and PTSD
ABC Mornings, January 18, 2022
Mind Medicine Australia chairman Peter Hunt says clinical trials in the use of psychedelic medicines could be “curative” for people living with mental illnesses.
Quest for new mental illness treatments continues with MDMA and psilocybin trial
Examiner, January 18, 2022
New research looking into the effects of MDMA and psilocybin on the brain is set to take place as part of a continuing push to make psychedelic medicines a mainstream treatment for depression and other mental health disorders
The Power of Psychedelic Assisted Therapies
Crappy to Happy Podcast, January 14, 2022
In this episode of the Crappy to Happy podcast, host Cass Dunn chats with Tania de Jong AM, who is a social entrepreneur, incredibly talented soprano and co-founder of the not-for-profit, Mind Medicine Australia.
Mind Medicine Australia joins global coalition launched to secure a rescheduling of psilocybin under the 1971 UN Convention on Psychotropic Substances
Mind Medicine Australia, January 13, 2022
Today Mind Medicine Australia joins in the launch of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI), a global coalition working to promote and secure a rescheduling of psilocybin under the 1971 Convention on Psychotropic Substances
Announcing a Major Healthy Persons Trial to Investigate the Brain Activity Effects of Psychedelic Medicines
Mind Medicine Australia, January 10, 2022
Mind Medicine Australia (MMA) is delighted to announce that it is part-funding a clinical trial which has just received Human Research Ethics approval and is designed to study the brain activity of participants after taking psychedelic medicines.
Find Your Voice: How This Acclaimed Australian Soprano Believes That Together We Can Change The World One Voice At A Time
Finding Genius Podcast, December 24, 2021
Our Executive Director Tania de Jong AM was interviewed in this podcast about her work with mental health charities Creativity Australia and Mind Medicine Australia.
From Investment Banking To Psychedelics: Changing The Treatment Paradigm For Mental Illness With Peter Hunt
Wake the f*** up podcast, December 21, 2021
This podcast is an exploration into Peter Hunt’s journey into spirituality and finding greater connection, meaning and peace which led to the establishment of Mind Medicine Australia with his wife Tania de Jong. It also explains why it is so urgent for psychedelic-assisted therapies to become part of our mental health system and the importance of Governments becoming proactive in this field, rather than reactive. There is so much suffering which could be alleviated through these transformational therapies.
Emyria to expand Real World Data assets for MDMA-assisted therapy trials by incorporating wearables monitoring
Emyria (ASX: EMD ) Press Release, December 20, 2021
Emyria’s phase 2b MDMA-assisted therapy trial for severe Post Traumatic Stress Disorder (PTSD), EMDMA-001, developed with registered charity Mind Medicine Australia (MMA), will be the first program to incorporate Cydelic technology and is expected to be one of the first programs in the world to incorporate remote patient monitoring within MDMA-assisted therapy.
TGA blocks use of MDMA, magic mushrooms trials for mental health
AFR, December 17, 2021
Australia’s medicines regulator has rejected a call to legalise psychedelic drugs for use in mental health settings.
TGA blocks bid to have MDMA, magic mushrooms used to treat mental health conditions
ABC News, December 16, 2021
Australia’s medicines regulator has rejected a call to legalise psychedelic drugs for use in mental health settings.
The Wellness Couch Podcast, Episode #92 with Tania de Jong AM
The Wellness Couch Podcast, December 16, 2021
In this podcast, Mind Medicine Australia Executive Director, Tania de Jong AM, shares more about psychedelic-assisted psychotherapies and their potential for healing mental illness.